Amedeo Smart

Free Medical Literature Service


 

Amedeo

Ischemic Heart Disease

  Free Subscription

14.08.2017

5 Am Heart J
13 Am J Cardiol
1 Am J Med
1 Ann Intern Med
1 Arterioscler Thromb Vasc Biol
1 BMJ
9 Can J Cardiol
2 Catheter Cardiovasc Interv
1 Circ Cardiovasc Genet
7 Circ Cardiovasc Imaging
1 Circ Cardiovasc Interv
3 Circ Cardiovasc Qual Outcomes
1 Circ Res
2 Circulation
13 Heart
4 Int J Cardiol
10 J Am Coll Cardiol
1 J Mol Cell Cardiol
1 J Thorac Cardiovasc Surg
1 JAMA
2 Lancet
1 Lancet Diabetes Endocrinol
1 Lancet Neurol
7 Mayo Clin Proc
7 PLoS One
1 Prog Cardiovasc Dis
2 Thromb Haemost



    Am Heart J

  1. KUTYIFA V, Beck C, Brown MW, Cannom D, et al
    Multicenter Automatic Defibrillator Implantation Trial-Subcutaneous Implantable Cardioverter Defibrillator (MADIT S-ICD): Design and clinical protocol.
    Am Heart J. 2017;189:158-166.
    >> Share

  2. COUTE RA, Ehrenfeld JM, Gupta DK, Terekhov MA, et al
    Electronically self-assessed functional capacity and exercise testing: A comparison of the Duke Activity Status Index and Patient-Reported Outcomes Measurement Information System tools.
    Am Heart J. 2017;188:82-86.
    >> Share

  3. KIM YG, Suh JW, Sibbing D, Kastrati A, et al
    A laboratory association between hemoglobin and VerifyNow P2Y12 reaction unit: A systematic review and meta-analysis.
    Am Heart J. 2017;188:53-64.
    >> Share

  4. MOGENSEN UM, Kober L, Kristensen SL, Jhund PS, et al
    The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF.
    Am Heart J. 2017;188:35-41.
    >> Share

  5. WIDMER RJ, Allison TG, Lennon R, Lopez-Jimenez F, et al
    Digital health intervention during cardiac rehabilitation: A randomized controlled trial.
    Am Heart J. 2017;188:65-72.
    >> Share


    Am J Cardiol

  6. QINTAR M, Smolderen KG, Chan PS, Gosch KL, et al
    Preinfarct Health Status and the Use of Early Invasive Versus Ischemia-Guided Management in Non-ST-Elevation Acute Coronary Syndrome.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31107.
    >> Share

  7. GIJSBERTS CM, Ellenbroek GHJM, Ten Berg MJ, Huisman A, et al
    Effect of Monocyte-to-Lymphocyte Ratio on Heart Failure Characteristics and Hospitalizations in a Coronary Angiography Cohort.
    Am J Cardiol. 2017 Jun 29. pii: S0002-9149(17)31028.
    >> Share

  8. OKUYA Y, Saito Y, Kitahara H, Nakayama T, et al
    Intraluminal Intensity of Blood Speckle on Intravascular Ultrasound, a Novel Predictor of Periprocedural Myocardial Injury After Coronary Stenting.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31105.
    >> Share

  9. MARAZZI G, Campolongo G, Pelliccia F, Quattrino S, et al
    Comparison of Low-Dose Statin Versus Low-Dose Statin + Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial).
    Am J Cardiol. 2017 Jun 28. pii: S0002-9149(17)31023.
    >> Share

  10. O'BRIEN C, Valsdottir L, Wasfy JH, Strom JB, et al
    Comparison of 30-Day Readmission Rates After Hospitalization for Acute Myocardial Infarction in Men Versus Women.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31108.
    >> Share

  11. ALSAMARAH A, Bansari A, Nasser H, Raza W, et al
    Comparison of the Appropriateness of Myocardial Perfusion Imaging in Men Versus Women.
    Am J Cardiol. 2017;120:191-195.
    >> Share

  12. KOH AS, Lye WK, Chia SY, Salunat-Flores J, et al
    Long-Term Prognostic Value of Appropriate Myocardial Perfusion Imaging.
    Am J Cardiol. 2017;119:1957-1962.
    >> Share

  13. CORTESE B, Ielasi A, Moscarella E, Loi B, et al
    Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry).
    Am J Cardiol. 2017;119:1924-1930.
    >> Share

  14. ALI M, Li Y, O'Neal WT, Soliman EZ, et al
    Tobacco Exposure as Determined by Serum Cotinine and Subclinical Myocardial Injury in Individuals Free from Cardiovascular Disease.
    Am J Cardiol. 2017 Jul 14. pii: S0002-9149(17)31112.
    >> Share

  15. NEZARAT N, Budoff MJ, Luo Y, Darabian S, et al
    Presence, Characteristics, and Volumes of Coronary Plaque Determined by Computed Tomography Angiography in Young Type 2 Diabetes Mellitus.
    Am J Cardiol. 2017 Mar 1. pii: S0002-9149(17)30209.
    >> Share

  16. GODSCHALK TC, Willemsen LM, Zwart B, Bergmeijer TO, et al
    Effect of Tailored Antiplatelet Therapy to Reduce Recurrent Stent Thrombosis and Cardiac Death After a First Episode of Stent Thrombosis.
    Am J Cardiol. 2017;119:1500-1506.
    >> Share

  17. TOMOMATSU T, Morishima I, Okumura K, Tsuboi H, et al
    Comparison of Frequency and Characteristics of Patients With Atrial Fibrillation Having Ablation With Versus Without Coronary Narrowing (>/=50%) by Angiography.
    Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30286.
    >> Share

  18. AMANO H, Koizumi M, Okubo R, Yabe T, et al
    Comparison of Coronary Intimal Plaques by Optical Coherence Tomography in Arteries With Versus Without Internal Running Vasa Vasorum.
    Am J Cardiol. 2017;119:1512-1517.
    >> Share


    Am J Med

  19. WEINTRAUB WS, Boden WE
    Making Cardiovascular Care More Responsive to Societal Needs.
    Am J Med. 2017 Aug 7. pii: S0002-9343(17)30798.
    >> Share


    Ann Intern Med

  20. KOLODZIEJCZAK M, Andreotti F, Kowalewski M, Buffon A, et al
    Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis.
    Ann Intern Med. 2017 Jun 27. doi: 10.7326/M17-0120.
    >> Share


    Arterioscler Thromb Vasc Biol

  21. THOMAS GD, Hamers AAJ, Nakao C, Marcovecchio P, et al
    Human Blood Monocyte Subsets: A New Gating Strategy Defined Using Cell Surface Markers Identified by Mass Cytometry.
    Arterioscler Thromb Vasc Biol. 2017;37:1548-1558.
    >> Share


    BMJ


  22. Gliflozins and reducing cardiovascular events . . . and other stories.
    BMJ. 2017;358:j3796.
    >> Share


    Can J Cardiol

  23. ALLEN DW, Ma B, Leung KC, Graham MM, et al
    Risk Prediction Models for Contrast-Induced Acute Kidney Injury Accompanying Cardiac Catheterization: Systematic Review and Meta-analysis.
    Can J Cardiol. 2017;33:724-736.
    >> Share

  24. KIMURA M, Kohno T, Kawakami T, Kataoka M, et al
    Midterm Effect of Balloon Pulmonary Angioplasty on Hemodynamics and Subclinical Myocardial Damage in Chronic Thromboembolic Pulmonary Hypertension.
    Can J Cardiol. 2016 Dec 8. pii: S0828-282X(16)31145.
    >> Share

  25. POTTER BJ, Matteau A, Mansour S, Naim C, et al
    Sustained Performance of a "Physicianless" System of Automated Prehospital STEMI Diagnosis and Catheterization Laboratory Activation.
    Can J Cardiol. 2017;33:148-154.
    >> Share

  26. CHRISTAKOPOULOS GE, Christopoulos G, Karmpaliotis D, Alaswad K, et al
    Predictors of Excess Patient Radiation Exposure During Chronic Total Occlusion Coronary Intervention: Insights From a Contemporary Multicentre Registry.
    Can J Cardiol. 2017;33:478-484.
    >> Share

  27. TRAN DT, Welsh RC, Ohinmaa A, Thanh NX, et al
    Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.
    Can J Cardiol. 2016 Dec 8. pii: S0828-282X(16)31144.
    >> Share

  28. TERADA T, Johnson JA, Norris C, Padwal R, et al
    Body Mass Index Is Associated With Differential Rates of Coronary Revascularization After Cardiac Catheterization.
    Can J Cardiol. 2017;33:822-829.
    >> Share

  29. HATEM R, Bebawi E, Schampaert E
    Potential Sunitinib-Induced Coronary Artery and Aortic Dissections.
    Can J Cardiol. 2017;33:830.
    >> Share

  30. BERTRAND OF, Ruzsa Z, Barria Perez A, De Larochelliere R, et al
    Same-Day Discharge After Transradial Percutaneous Coronary Intervention and Carotid Stenting in a Single Session.
    Can J Cardiol. 2017;33:830.
    >> Share

  31. DUAN C, Cao Y, Liu Y, Zhou L, et al
    A New Preprocedure Risk Score for Predicting Contrast-Induced Acute Kidney Injury.
    Can J Cardiol. 2017;33:714-723.
    >> Share


    Catheter Cardiovasc Interv

  32. SETO AH, Kern MJ
    Breaking the code: What is the best post-PCI MI definition?
    Catheter Cardiovasc Interv. 2017;89:857-859.
    >> Share

  33. SANDOVAL Y, Brilakis ES
    The role of rotational atherectomy in contemporary chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2017;89:829-831.
    >> Share


    Circ Cardiovasc Genet

  34. BROWN SN, Jouni H, Marroush TS, Kullo IJ, et al
    Effect of Disclosing Genetic Risk for Coronary Heart Disease on Information Seeking and Sharing: The MI-GENES Study (Myocardial Infarction Genes).
    Circ Cardiovasc Genet. 2017;10.
    >> Share


    Circ Cardiovasc Imaging

  35. FEHER A, Sinusas AJ
    Quantitative Assessment of Coronary Microvascular Function: Dynamic Single-Photon Emission Computed Tomography, Positron Emission Tomography, Ultrasound, Computed Tomography, and Magnetic Resonance Imaging.
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  36. LIU D, Borlotti A, Viliani D, Jerosch-Herold M, et al
    CMR Native T1 Mapping Allows Differentiation of Reversible Versus Irreversible Myocardial Damage in ST-Segment-Elevation Myocardial Infarction: An OxAMI Study (Oxford Acute Myocardial Infarction).
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  37. YOUSSEF AA, Yang PC
    T1 Map of Post-Myocardial Infarction for Precise Tissue Characterization.
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  38. TAQUETI VR, Blankstein R
    Understanding Sex Differences in Coronary Artery Disease Risk: Is Coronary Anatomy Sufficient?
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  39. XIE JX, Eshtehardi P, Varghese T, Goyal A, et al
    Prognostic Significance of Nonobstructive Left Main Coronary Artery Disease in Women Versus Men: Long-Term Outcomes From the CONFIRM (Coronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter) Registry.
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  40. GARG P, Plein S
    Native T1 Mapping: Adding a New Dimension to the Characterization of Acute Myocardial Infarction.
    Circ Cardiovasc Imaging. 2017;10.
    >> Share

  41. HABERKORN SM, Jacoby C, Ding Z, Keul P, et al
    Cardiovascular Magnetic Resonance Relaxometry Predicts Regional Functional Outcome After Experimental Myocardial Infarction.
    Circ Cardiovasc Imaging. 2017;10.
    >> Share


    Circ Cardiovasc Interv

  42. PIROTH Z, Toth GG, Tonino PAL, Barbato E, et al
    Prognostic Value of Fractional Flow Reserve Measured Immediately After Drug-Eluting Stent Implantation.
    Circ Cardiovasc Interv. 2017;10.
    >> Share


    Circ Cardiovasc Qual Outcomes

  43. PI Y, Roe MT, Holmes DN, Chiswell K, et al
    Utilization, Characteristics, and In-Hospital Outcomes of Coronary Artery Bypass Grafting in Patients With ST-Segment-Elevation Myocardial Infarction: Results From the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Out
    Circ Cardiovasc Qual Outcomes. 2017;10.
    >> Share

  44. DOLL JA, Overton R, Patel MR, Rao SV, et al
    Morbidity and Mortality Conference for Percutaneous Coronary Intervention.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    >> Share

  45. AGARWAL S, Thakkar B, Skelding KA, Blankenship JC, et al
    Trends and Outcomes After Same-Day Discharge After Percutaneous Coronary Interventions.
    Circ Cardiovasc Qual Outcomes. 2017;10.
    >> Share


    Circ Res

  46. AMBALE-VENKATESH B, Yang X, Wu CO, Liu K, et al
    Cardiovascular Event Prediction by Machine Learning: The Multi-Ethnic Study of Atherosclerosis.
    Circ Res. 2017 Aug 9. pii: CIRCRESAHA.117.311312.
    >> Share


    Circulation

  47. KANDZARI DE, Smits PC, Love MP, Ben-Yehuda O, et al
    Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents in Patients with Coronary Artery Disease: Primary Results from the BIONICS Trial.
    Circulation. 2017 Aug 9. pii: CIRCULATIONAHA.117.028885.
    >> Share

  48. SARDELLA G, Mancone M, Stio RE, Cavallo E, et al
    Prasugrel or Ticagrelor in ST-Segment-Elevation Myocardial Infarction Patients With Diabetes Mellitus.
    Circulation. 2017;136:602-604.
    >> Share


    Heart

  49. OHYA M, Kubo S, Kuwayama A, Miura K, et al
    Long-term (8-10 years) outcomes after biodegradable polymer-coated biolimus-eluting stent implantation.
    Heart. 2017;103:1002-1008.
    >> Share

  50. PERERA D, Uppal R, Hogan J
    A 72-year-old male with recurrent syncope.
    Heart. 2017;103:800.
    >> Share

  51. BERG J, Bjorck L, Nielsen S, Lappas G, et al
    Sex differences in survival after myocardial infarction in Sweden, 1987-2010.
    Heart. 2017 Aug 7. pii: heartjnl-2016-310281. doi: 10.1136/heartjnl-2016-310281.
    >> Share

  52. NAIROOZ R, Saad M, Sardar P, Aronow WS, et al
    Two-year outcomes of bioresorbable vascular scaffold versus drug-eluting stents in coronary artery disease: a meta-analysis.
    Heart. 2017;103:1096-1103.
    >> Share

  53. HELSEN F, Vandenberk B, De Meester P, Van De Bruaene A, et al
    Appearance of QRS fragmentation late after Mustard/Senning repair is associated with adverse outcome.
    Heart. 2017;103:1036-1042.
    >> Share

  54. SHIMADA YJ, Tsugawa Y, Iso H, Brown DF, et al
    Association between bariatric surgery and rate of hospitalisations for stable angina pectoris in obese adults.
    Heart. 2017;103:1009-1014.
    >> Share

  55. WILLIAMS MC, Hunter A, Shah A, Assi V, et al
    Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial.
    Heart. 2017 Feb 28. pii: heartjnl-2016-310129. doi: 10.1136/heartjnl-2016-310129
    >> Share

  56. ZHOU RH, Yu H, Yin XR, Li Q, et al
    Effect of intralipid postconditioning on myocardial injury in patients undergoing valve replacement surgery: a randomised controlled trial.
    Heart. 2017;103:1122-1127.
    >> Share

  57. GONZALEZ LOPEZ-VALCARCEL B, Librero J, Garcia-Sempere A, Pena LM, et al
    Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome.
    Heart. 2017;103:1082-1088.
    >> Share

  58. TIMMIS A, Roobottom CA
    National Institute for Health and Care Excellence updates the stable chest pain guideline with radical changes to the diagnostic paradigm.
    Heart. 2017;103:982-986.
    >> Share

  59. MAZNYCZKA AM, McCartney P, Berry C
    Reference invasive tests of microvascular injury in myocardial infarction.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311695. doi: 10.1136/heartjnl-2017-311695.
    >> Share

  60. ALFREDSSON J, Neely B, Neely ML, Bhatt DL, et al
    Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes.
    Heart. 2017;103:1168-1176.
    >> Share

  61. LI X, Yu C, Guo Y, Bian Z, et al
    Tea consumption and risk of ischaemic heart disease.
    Heart. 2017;103:783-789.
    >> Share


    Int J Cardiol

  62. POULSEN CB, Al-Mashhadi AL, Bentzon JF, Falk E, et al
    REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing.
    Int J Cardiol. 2017;229:8.
    >> Share

  63. FAN ZX, Yang CJ, Yang J, Yang J, et al
    Stains: A novel therapy thought in myocardial ischemia reperfusion injury other than lipid lowering.
    Int J Cardiol. 2017;229:10.
    >> Share

  64. VON JEINSEN B, Kraus D, Palapies L, Tzikas S, et al
    Urinary neutrophil gelatinase-associated lipocalin and cystatin C compared to the estimated glomerular filtration rate to predict risk in patients with suspected acute myocardial infarction.
    Int J Cardiol. 2017 Jul 25. pii: S0167-5273(16)34646.
    >> Share

  65. MAZZOTTA G, Caretta G
    "Off-hours" presentation in ST-elevation myocardial infarction: do not rest on the seventh day.
    Int J Cardiol. 2017;244:331-332.
    >> Share


    J Am Coll Cardiol

  66. NEWMAN JD, Schwartzbard AZ, Weintraub HS, Goldberg IJ, et al
    Primary Prevention of Cardiovascular Disease in Diabetes Mellitus.
    J Am Coll Cardiol. 2017;70:883-893.
    >> Share

  67. GAYE B, Djousse L, Empana JP
    Low-Risk Lifestyle Is a Strong Predictor of Outcomes Across Populations With Different Cardiovascular Health Manifestations.
    J Am Coll Cardiol. 2017;70:910.
    >> Share

  68. LV J, Qi L, Li L
    Reply: Low-Risk Lifestyle Is a Strong Predictor of Outcomes Across Populations With Different Cardiovascular Health Manifestations.
    J Am Coll Cardiol. 2017;70:910-911.
    >> Share

  69. LI D, Yu J, Zeng R, Zhao L, et al
    Neutrophil Count Is Associated With Risks of Cardiovascular Diseases.
    J Am Coll Cardiol. 2017;70:911-912.
    >> Share

  70. LONBORG J, Engstrom T, Ahtarovski KA, Nepper-Christensen L, et al
    Myocardial Damage in Patients With Deferred Stenting After STEMI: A DANAMI-3-DEFER Substudy.
    J Am Coll Cardiol. 2017;69:2794-2804.
    >> Share

  71. NEJATIAN A, Omstedt A, Hoijer J, Hansson LO, et al
    Outcomes in Patients With Chest Pain Discharged After Evaluation Using a High-Sensitivity Troponin T Assay.
    J Am Coll Cardiol. 2017;69:2622-2630.
    >> Share

  72. SHAH AD, Denaxas S, Nicholas O, Hingorani AD, et al
    Reply: Neutrophil Count Is Associated With Risks of Cardiovascular Diseases.
    J Am Coll Cardiol. 2017;70:912.
    >> Share

  73. OMLAND T, Kullo IJ
    Biomarker-Based Risk Models to Risk Stratify Patients With Stable Coronary Heart Disease.
    J Am Coll Cardiol. 2017;70:827-829.
    >> Share

  74. JEREMIAS A, Kirtane AJ, Stone GW
    A Test in Context: Fractional Flow Reserve: Accuracy, Prognostic Implications, and Limitations.
    J Am Coll Cardiol. 2017;69:2748-2758.
    >> Share

  75. LINDHOLM D, Lindback J, Armstrong PW, Budaj A, et al
    Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease.
    J Am Coll Cardiol. 2017;70:813-826.
    >> Share


    J Mol Cell Cardiol

  76. POE AJ, Knowlton AA
    Exosomes as agents of change in the cardiovascular system.
    J Mol Cell Cardiol. 2017;111:40-50.
    >> Share


    J Thorac Cardiovasc Surg

  77. NGUYEN TC, Charitakis K
    Fractional flow reserve-guided coronary artery bypass grafting: Less is more?
    J Thorac Cardiovasc Surg. 2017 Jul 19. pii: S0022-5223(17)31402.
    >> Share


    JAMA

  78. CHOLLEY B, Caruba T, Grosjean S, Amour J, et al
    Effect of Levosimendan on Low Cardiac Output Syndrome in Patients With Low Ejection Fraction Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass: The LICORN Randomized Clinical Trial.
    JAMA. 2017;318:548-556.
    >> Share


    Lancet

  79. JOBS A, Mehta SR, Montalescot G, Vicaut E, et al
    Optimal timing of an invasive strategy in patients with non-ST-elevation acute coronary syndrome: a meta-analysis of randomised trials.
    Lancet. 2017 Aug 1. pii: S0140-6736(17)31490.
    >> Share

  80. DAMMAN P, de Winter RJ
    Timing of revascularisation for acute coronary syndrome.
    Lancet. 2017 Aug 1. pii: S0140-6736(17)31632.
    >> Share


    Lancet Diabetes Endocrinol

  81. BIRKELAND KI, Jorgensen ME, Carstensen B, Persson F, et al
    Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis.
    Lancet Diabetes Endocrinol. 2017 Aug 3. pii: S2213-8587(17)30258.
    >> Share


    Lancet Neurol

  82. LOGALLO N, Novotny V, Assmus J, Kvistad CE, et al
    Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
    Lancet Neurol. 2017 Aug 2. pii: S1474-4422(17)30253.
    >> Share


    Mayo Clin Proc

  83. CLEGG DJ, Cody M, Palmer BF
    Challenges in Treating Cardiovascular Disease: Restricting Sodium and Managing Hyperkalemia.
    Mayo Clin Proc. 2017;92:1248-1260.
    >> Share

  84. ROSENTHAL RL
    Revisiting the Historical Origins of Clinically Meaningful Coronary Artery Obstruction.
    Mayo Clin Proc. 2017;92:1312.
    >> Share

  85. RUMBERGER JA
    In Reply-Revisiting the Historical Origins of Clinically Meaningful Coronary Artery Obstruction.
    Mayo Clin Proc. 2017;92:1312-1313.
    >> Share

  86. GANATRA S, Sharma A, Levy MS
    A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology Revisited.
    Mayo Clin Proc. 2017;92:1315-1316.
    >> Share

  87. AL-KINDI SG, Oliveira GH
    In Reply I-A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology Revisited.
    Mayo Clin Proc. 2017;92:1316-1317.
    >> Share

  88. WANG F, Herrmann J
    In Reply II-A Differing Opinion on Primary Percutaneous Coronary Intervention in Patients Who Have Had Cancer: Stent Choice in Onco-cardiology Revisited.
    Mayo Clin Proc. 2017;92:1317-1318.
    >> Share

  89. CHOWDHARY VR
    Broad Concepts in Management of Systemic Lupus Erythematosus.
    Mayo Clin Proc. 2017;92:744-761.
    >> Share


    PLoS One

  90. BUNDHUN PK, Soogund MZ, Huang WQ
    Same Day Discharge versus Overnight Stay in the Hospital following Percutaneous Coronary Intervention in Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    PLoS One. 2017;12:e0169807.
    >> Share

  91. LUTFI MF
    Anxiety Level and Cardiac Autonomic Modulations in Coronary Artery Disease and Cardiac Syndrome X Patients.
    PLoS One. 2017;12:e0170086.
    >> Share

  92. LI Z, Zhou Y, Xu Q, Chen X, et al
    Staged versus One-Time Complete Revascularization with Percutaneous Coronary Intervention in STEMI Patients with Multivessel Disease: A Systematic Review and Meta-Analysis.
    PLoS One. 2017;12:e0169406.
    >> Share

  93. ZENG WP, Zhang R, Li R, Luo JF, et al
    Association of the Endothelial Nitric Oxide Synthase Gene T786C Polymorphism with In-Stent Restenosis in Chinese Han Patients with Coronary Artery Disease Treated with Drug-Eluting Stent.
    PLoS One. 2017;12:e0170964.
    >> Share

  94. TAI SY, Chien CY, Wu DC, Lin KD, et al
    Risk of dementia from proton pump inhibitor use in Asian population: A nationwide cohort study in Taiwan.
    PLoS One. 2017;12:e0171006.
    >> Share

  95. YU J, Oh PC, Kim M, Moon J, et al
    Improved early risk stratification of patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention using a combination of serum soluble ST2 and NT-proBNP.
    PLoS One. 2017;12:e0182829.
    >> Share

  96. GEBHARD C, Rheaume E, Berry C, Brand G, et al
    Beneficial Effects of Reconstituted High-Density Lipoprotein (rHDL) on Circulating CD34+ Cells in Patients after an Acute Coronary Syndrome.
    PLoS One. 2017;12:e0168448.
    >> Share


    Prog Cardiovasc Dis

  97. LAVIE CJ
    From Heart Failure to Journal Metrics-Making Progress in Cardiovascular Diseases.
    Prog Cardiovasc Dis. 2017 Aug 3. pii: S0033-0620(17)30108.
    >> Share


    Thromb Haemost

  98. HARADA Y, Michel J, Lohaus R, Mayer K, et al
    Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
    Thromb Haemost. 2017;117.
    >> Share

  99. ANETSBERGER A, Blobner M, Haller B, Schmid S, et al
    Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery.
    Thromb Haemost. 2017;117.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016